Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001213900-23-032961
Filing Date
2023-04-27
Accepted
2023-04-27 06:09:55
Documents
4
Period of Report
2023-04-27

Document Format Files

Seq Description Document Type Size
1 REPORT OF FOREIGN PRIVATE ISSUER ea177545-6k_alterity.htm 6-K 17377
2 APPENDIX 4C AND QUARTERLY CASH FLOW REPORT ea177545ex99-1_alterity.htm EX-99.1 141123
3 GRAPHIC ex99-1_001.jpg GRAPHIC 106427
4 GRAPHIC ex99-1_002.jpg GRAPHIC 4064
  Complete submission text file 0001213900-23-032961.txt   312022
Mailing Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000
Business Address LEVEL 3, 460 BOURKE STREET MELBOURNE C3 VIC 3000 61 3 9349 4906
ALTERITY THERAPEUTICS LTD (Filer) CIK: 0001131343 (see all company filings)

IRS No.: 000000000 | State of Incorp.: C3 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-49843 | Film No.: 23851621
SIC: 2834 Pharmaceutical Preparations